Florian Moik

3.3k total citations · 3 hit papers
66 papers, 2.0k citations indexed

About

Florian Moik is a scholar working on Internal Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Florian Moik has authored 66 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Internal Medicine, 26 papers in Oncology and 19 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Florian Moik's work include Venous Thromboembolism Diagnosis and Management (38 papers), Inflammatory Biomarkers in Disease Prognosis (13 papers) and Central Venous Catheters and Hemodialysis (11 papers). Florian Moik is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (38 papers), Inflammatory Biomarkers in Disease Prognosis (13 papers) and Central Venous Catheters and Hemodialysis (11 papers). Florian Moik collaborates with scholars based in Austria, Russia and United States. Florian Moik's co-authors include Cihan Ay, Ingrid Pabinger, Stephan Nopp, Bernd Jilma, Nick van Es, Hanneke W.M. van Laarhoven, Frits I. Mulder, Henrik Toft Sørensen, Harry R. Büller and Erzsébet Horváth–Puhó and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Florian Moik

60 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Venous thromboembolism in cancer patients: a population-based cohort study

2020 399 citations Frits I. Mulder, Erzsébet Horváth–Puhó et al. Blood profile →
Cancer-associated venous thromboembolism

2022 235 citations Ingrid Pabinger, Florian Moik et al. profile →
Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of Life

2022 156 citations Stephan Nopp, Florian Moik et al. Respiration profile →

Peers

Countries citing papers authored by Florian Moik

Since Specialization

Citations

This map shows the geographic impact of Florian Moik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Moik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Moik more than expected).

Fields of papers citing papers by Florian Moik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Moik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Moik. The network helps show where Florian Moik may publish in the future.

Co-authorship network of co-authors of Florian Moik

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Moik. A scholar is included among the top collaborators of Florian Moik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Moik. Florian Moik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort study 2025 ·EClinicalMedicine ·Florian Moik, Erzsébet Horváth–Puhó, Cihan Ay, Ingrid Pabinger, Frits I. Mulder, Nick van Es, Henrik Toft Sørensen	0
2	Prevention and Treatment of Venous Thromboembolism Associated with Amivantamab-Based Therapies in Patients with Lung Cancer—Provisional Clinical Opinion Based on Existing Clinical Practice Guidelines 2025 ·Cancers ·Florian Moik, Gudrun Absenger, (unknown), Maximilian J. Hochmair, Cihan Ay	2
3	Growth Differentiation Factor-15 Predicts Major Bleeding in Cancer Patients 2025 ·JACC CardioOncology ·(unknown), Stephan Nopp, Florian Moik, Daniel Steiner, Angelika M. Starzer, Monika Fritzer‐Szekeres, Matthias Preusser, Anna S. Berghoff, Ingrid Pabinger, Cihan Ay	0
4	The Vienna CATScore for predicting cancer-associated venous thromboembolism: an external validation across multiple time points 2025 ·ESMO Open ·(unknown), Stephan Nopp, Florian Moik, Angelika M. Starzer, Peter Quehenberger, Matthias Preusser, Anna S. Berghoff, Cihan Ay, Ingrid Pabinger	2
5	Targeted anti-cancer agents and risk of venous thromboembolism 2024 ·Haematologica ·Melina Verso, Florian Moik, (unknown), Alexander T. Cohen	2
6	530P Real-world effectiveness and predictive biomarker analysis of TAS-102+bevacizumab vs. regorafenib vs. TAS-102 in metastatic colorectal cancer: A multicenter cohort study 2024 ·Annals of Oncology ·Andreas Seeber, (unknown), Bernhard Doleschal, Hossein Taghizadeh, (unknown), Florian Moik, (unknown), Ludwig Wagner, (unknown), (unknown), (unknown), Arno Amann, Dominik Wolf‎, Richard Greil, Philipp J. Jost, Thomas Winder, Holger Rumpold, (unknown), Armin Gerger, Jakob M. Riedl	0
7	Bleeding events in patients with cancer: incidence, risk factors, and impact on prognosis in a prospective cohort study 2024 ·Blood ·(unknown), Florian Moik, Daniel Steiner, Angelika M. Starzer, Anna S. Berghoff, Matthias Preusser, Ingrid Pabinger, Cihan Ay	12
8	Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study 2023 ·Journal of Thrombosis and Haemostasis ·Stephan Nopp, Florian Moik, Simon Kraler, (unknown), Matthias Preusser, Arnold von Eckardstein, Ingrid Pabinger, Thomas F. Lüscher, Cihan Ay	4
9	Tissue Factor Pathway Inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer 2023 ·Hämostaseologie ·(unknown), Florian Moik, J. Thaler, Silvia Koder, Matthias Preusser, Ingrid Pabinger, Cihan Ay	1
10	PB0919 High Rates of Bleeding in Unselected Patients with Cancer: Results from a Prospective Cohort Study 2023 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), Florian Moik, Daniel Steiner, Anna S. Berghoff, Matthias Preusser, Ingrid Pabinger, Cihan Ay	1
11	Pharmacokinetic-guided versus standard prophylaxis in hemophilia: a systematic review and meta-analysis 2023 ·Journal of Thrombosis and Haemostasis ·(unknown), Oliver Königsbrügge, Florian Moik, Brigitte Wildner, Cihan Ay, Ingrid Pabinger	1
12	Neutrophils in lung cancer patients: Activation potential and neutrophil extracellular trap formation 2023 ·Research and Practice in Thrombosis and Haemostasis ·Lisa‐Marie Mauracher, Lena Hell, Florian Moik, (unknown), (unknown), (unknown), Ella Grilz, Thomas M. Hofbauer, Christine Brostjan, Sylvia Knapp, Cihan Ay, Ingrid Pabinger	13
13	Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of Life breakdown → 2022 ·Respiration ·Stephan Nopp, Florian Moik, Frederikus A. Klok, (unknown), Miloš Petrović, Karin Vonbank, Andreas Rembert Koczulla, Cihan Ay, Ralf Harun Zwick	156
14	Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer 2022 ·International Journal of Molecular Sciences ·(unknown), Oliver Königsbrügge, Stephan Nopp, Florian Moik, Peter Quehenberger, Matthias Preusser, Ingrid Pabinger, Cihan Ay	2
15	ABO blood group type and risk of venous thromboembolism in patients with cancer 2022 ·Blood Advances ·(unknown), Florian Moik, Stephan Nopp, Markus Raderer, Ingrid Pabinger, Cihan Ay	22
16	Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies 2022 ·Thrombosis Research ·Florian Moik, Cihan Ay	22
17	Outpatient Pulmonary Rehabilitation in Patients with Persisting Symptoms after Pulmonary Embolism 2020 ·Journal of Clinical Medicine ·Stephan Nopp, Frederikus A. Klok, Florian Moik, Miloš Petrović, (unknown), Cihan Ay, Ralf Harun Zwick	30
18	Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis 2020 ·Research and Practice in Thrombosis and Haemostasis ·Stephan Nopp, Florian Moik, Bernd Jilma, Ingrid Pabinger, Cihan Ay	286
19	Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future 2020 ·Thrombosis Research ·Florian Moik, Cihan Ay, Ingrid Pabinger	41
20	How I treat cancer-associated thrombosis 2019 ·ESMO Open ·Florian Moik, Ingrid Pabinger, Cihan Ay	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact